SCHEMBL3241017

SCHEMBL3241017

CC1=C(C(=O)OCc2ccccc2)C(c2ccc3ccccc3c2)c2cn[nH]c2N1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 4/20 0.59
CACNA1B Q00975 1/20 0.54
POLB P06746 1/20 0.47
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
GPBAR1 Q8TDU6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3002847 0.89 PDE1C (0.54) PDE1CCYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL3004824 0.87 PDE1C (0.69) PDE1CCACNA1BPOLBCYP3A4CYP2C9
SCHEMBL4258159 0.83 PDE1C (0.57) PDE1CCACNA1BPOLBCYP3A4CYP2C9
SCHEMBL3242915 0.81 PDE1C (0.48) PDE1CMEN1KMT2AGPBAR1
SCHEMBL4260613 0.80 ADORA2B (0.57) PDE1CPOLBKDM4EALDH1A1MEN1
SCHEMBL3237974 0.79 TSHR (0.44) PDE1CCACNA1BMAPTTSHR
SCHEMBL2996950 0.79 PDE1C (0.45) PDE1CGAATSHR
SCHEMBL4260307 0.79 PDE1C (0.36) PDE1CCACNA1BPOLB
SCHEMBL3000827 0.78 PDE1C (0.45) PDE1CALDH1A1
SCHEMBL3006899 0.77 PDE1C (0.44) PDE1CKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010002483-A1 OPTIONALLY CONDENSED DIHYDRO PYRIDINE, DIHYDROPYRIMIDINE AND DIHYDRO PYRANE DERIVATIVES ACTING AS LATE SODIUM CHANNEL BLOCKERS CV THERAPEUTICS, INC. (US) 2010-01-07 WO disclosed